The fourth annual meeting of the American Mathematical Society

American society of hematology 49th annual meeting.

In a clinical trial among 187 patients with paroxysmal nocturnal hemolysis (PNH), treatment with eculizumab (Soliris, Alexion), a terminal complement inhibitor, significantly reduced hemolysis and thrombosis and improved anemia and fatigue in several participating subgroups. Dr. Bessler noted that the disease burden had not previously been determined in these patients, who had lower lactate deh...

American Society of Hematology 2015 Annual Meeting.

The annual meeting of the American Society of Hematology drew 25,000 attendees for the presentation of 5,633 abstracts. We review key sessions focusing on newer agents and their efficacy in high-risk leukemia and multiple myeloma populations.

Ninety-fourth annual report of the american phytopathological society.

Thirty-ninth annual meeting of the American Society of Neuroradiology.

The 50th Annual Meeting of American Society of Hematology